2017
DOI: 10.2174/1389203717666160311121433
|View full text |Cite
|
Sign up to set email alerts
|

Structure and Function of Fbxo7/PARK15 in Parkinson's Disease

Abstract: Fbxo7/PARK15 has well-defined roles, acting as part of a Skp1-Cul1-F box protein (SCF)- type E3 ubiquitin ligase and also having SCF-independent activities. Mutations within FBXO7 have been found to cause an early-onset Parkinson's disease, and these are found within or near to its functional domains, including its F-box domain (FBD), its proline rich region (PRR), and its ubiquitinlike domain (Ubl). We highlight recent advances in our understanding of Fbxo7 function in Parkinson's disease, with respect to the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 22 publications
(26 citation statements)
references
References 77 publications
1
25
0
Order By: Relevance
“…In this regard, biochemical findings in Drosophila showed that overexpression of wild-type FBXO7 suppresses mitochondrial disruption and also neurodegeneration process in PARKIN mutants, confirming that they share a common role in mitochondrial biology (Burchell et al 2013 ; Zhou et al 2016 ). As a result, it is assumed that FBXO7 functions in a common pathway with PARKIN and PINK1 to induce selective autophagic clearance (mitophagy) in response to damaged mitochondria and pathogenic mutations in FBXO7 may interfere with this pathway (Conedera et al 2016 ; Randle and Laman 2017 ; Vingill et al 2016 ).…”
Section: Pink1 Parkin and Mitochondrial Hemostasismentioning
confidence: 99%
“…In this regard, biochemical findings in Drosophila showed that overexpression of wild-type FBXO7 suppresses mitochondrial disruption and also neurodegeneration process in PARKIN mutants, confirming that they share a common role in mitochondrial biology (Burchell et al 2013 ; Zhou et al 2016 ). As a result, it is assumed that FBXO7 functions in a common pathway with PARKIN and PINK1 to induce selective autophagic clearance (mitophagy) in response to damaged mitochondria and pathogenic mutations in FBXO7 may interfere with this pathway (Conedera et al 2016 ; Randle and Laman 2017 ; Vingill et al 2016 ).…”
Section: Pink1 Parkin and Mitochondrial Hemostasismentioning
confidence: 99%
“…In a similar vein to the sperm maturation defects, Fbxo7 has also been shown to be required during the final maturation steps of erythrocytes. We previously reported Fbxo7 LacZ/LacZ mice are anemic due to delayed mitophagy and defects in exiting cell cycle (Randle and Laman, 2016). Importantly, during this maturation step, macrophages in erythroblast islands phagocytose the shed organelles from maturing reticulocytes (Geminard et al, 2002; Zhang et al, 2015; Ovchynnikova et al, 2018), a process requiring the coupling of the autophagy and exocytosis pathways (Mankelow et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…This protein is likely essential for LANCL2 mediated downregulation of inflammatory pathways because of its previously explored abilities to mark important TNF and TRAF signaling molecules for degradation [52]. Notably, Fbxo7 and members of the LanC-like family have been shown to impact similar neurological disorders [53,54]. Moreover, LANCL2 is important for the production of secondary messengers such as cAMP and Ca 2+ , which help to drive PKA and calmodulin events needed for the elevated production of IL-10 [48].…”
Section: Discussionmentioning
confidence: 99%